[Autoantibodies against NMDA-receptors in the blood of patients with acute disorders of cerebral circulation].

Concentration of autoantibodies to human brain NMDA-receptor in blood serum of patients with acute brain ischemic stroke was significantly higher than in healthy persons and patients with other neurological diseases. Average content of cholesterol, lipid peroxides and glutamate in the serum were close in all patient groups investigated. It was suggested that the content of autoantibodies to human brain NMDA-receptor could be used as biochemical criteria for acute brain stroke patient's condition control and their treatment efficiency.

[The use of the clinical biochemical Epitest kit in children with epilepsy].

57 children aged 3-15 years were examined: children with epilepsy (n = 26), children with epileptic syndrome (n = 16) and children with other neurologic pathology (n = 15). Control group included 25 healthy children. Diagnostic efficiency of the epileptic test was investigated on the basis of the detection of autoantibodies (aAb) to glutamate receptor of AMPA type in blood serum of the patients.